Once the KQs were finalized, the Work Group prioritized the outcomes they had defined for each KQ based on how important the Work Group judged each outcome to be. Ranking outcomes by their relative importance can help focus attention on those outcomes that are considered most important for clinical decision making when making judgments regarding the overall quality of the evidence to support a Using GRADE methodology, the Work Group rated each outcome on a 1 9 scale (7 9, critical for decision making; 4 6, important, but not critical, for decision making; and 1 3, of limited importance for decision making). Critical and important outcomes were included in the evidence review (see Outcomes); however, only outcomes judged to be critical were used to determine the overall quality of evidence (see Grading Recommendations). a. Population(s) Key Question 1: Individuals previously screened for CVD risk and with risk score below 10 20% Key Question 2: All adults Key Question 3: All adults eligible for primary prevention Specific to adults who are at risk of CVD or already have dyslipidemia Key Question 8: Patients who have been taking a statin for 3 or more years for primary or secondary prevention b. Interventions Key Question 1: Repeat CVD risk assessment Key Question 2: Lipid lab test Key Question 3 CV risk stratification: Use of risk models (e.g., pooled cohort risk score versus FRS versus biology-based risk assessment). 